Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
29 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 29.5236 | 825 | 24.36 k | 83,664 |
22 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 30.4255 | 3,948 | 120.12 k | 84,489 |
21 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Grant | Acquire A | No | No | 0 | 36,426 | 0.00 | 88,437 |
17 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 29.9582 | 2,145 | 64.26 k | 52,011 |
13 Jan 25 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 28.7021 | 2,632 | 75.54 k | 54,156 |
13 Mar 24 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 58.1335 | 3,452 | 200.68 k | 56,287 |
13 Mar 24 | APLS Apellis Pharmaceuticals | Common Stock | Sell | Dispose S | No | No | 57.307 | 7,768 | 445.16 k | 59,739 |